CHAGAS VIRCLIA® IGG+IGM MONOTEST - INVIMA Registration ae9367732e716a7dc6d7cfd52c2248dd
Access comprehensive regulatory information for CHAGAS VIRCLIA® IGG+IGM MONOTEST (CHAGAS VIRCLIA® IGG+IGM MONOTEST) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID ae9367732e716a7dc6d7cfd52c2248dd and manufactured by ANNAR DIAGNOSTICA IMPORT S.A.S..
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO (CLIA) PARA DETERMINAR ANTICUERPOS _x000D_ IGG+IGM ESPECÍFICOS FRENTE A TRYPANOSOMA CRUZI EN SUERO/PLASMA HUMANO. _x000D_ ESTE PRODUCTO ES UN ANÁLISIS CUALITATIVO Y AUTOMATIZADO, DESTINADO PARA SER USADO _x000D_ COMO AYUDA AL DIAGNÓSTICO.
INDIRECT CHEMILUMINESCENT IMMUNOASSAY (CLIA) TO DETERMINE ANTIBODIES _x000D_ IGG+IGM SPECIFIC TO TRYPANOSOMA CRUZI IN HUMAN SERUM/PLASMA. _x000D_ THIS PRODUCT IS A QUALITATIVE AND AUTOMATED ANALYSIS, INTENDED TO BE USED _x000D_ AS AN AID TO DIAGNOSIS.